My Choice TM

Manufacturer
NuCare Pharmaceuticals,Inc.
Effective date
2021-02-16
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:52:13

Label at a glance#

ProductMy Choice TM
Active ingredientLEVONORGESTREL
Label structure13 sections

Dosage and administration

take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it, the better it will work.  if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Levonorgestrel 1.5mg

Purpose

OTC - PURPOSE SECTION

Emergency contraceptive

Use

INDICATIONS & USAGE SECTION

for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)



Warnings

WARNINGS SECTION

Allergy alert:

SPL UNCLASSIFIED SECTION

Do not use if you have ever had an allergic reaction to levonorgestrel

Sexually transmitted diseases (STDs) alert:

SPL UNCLASSIFIED SECTION


This product does not protect against HIV/AIDS or other STDs.



Do not use

OTC - DO NOT USE SECTION

  • if you are already pregnant (because it will not work)
  • for regular birth control

When using this product you may have

OTC - WHEN USING SECTION

• menstrual changes • tiredness • dizziness • nausea • headache • breast pain • lower stomach (abdominal) pain • vomiting

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).



Directions

DOSAGE & ADMINISTRATION SECTION

    • take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it, the better it will work. 
    • if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose

Other information

SPL UNCLASSIFIED SECTION

  • read the instructions, warnings, and enclosed product leaflet before use
  • this product works mainly by preventing ovulation (egg release). It may also prevent fertilization of a released egg (joining of sperm and egg) or attachment of a fertilized egg to the uterus (implantation). 
  • do not use if carton is open or tear strip is removed or blister seal is broken or missing
  • store at 20° to 25°C (68° to 77°F)

Inactive ingredient

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, corn starch, hypromellose, lactose monohydrate, magnesium stearate, talc

Questions or comments?

SPL UNCLASSIFIED SECTION

For more information, call toll free 1-800-818-4555 weekdays

SPL UNCLASSIFIED SECTION

My Choice TM

(levonorgestrel) Tablet, 1.5 mg

Emergency Contraceptive

One Tablet. One Step.

What You Need to Know

What is My Choice?

My Choice is emergency contraception that helps prevent pregnancy after birth control failure or unprotected sex. It is a backup method of preventing pregnancy and should not be used as regular birth control.


What My Choice is not.

My Choice will not work if you are already pregnant and will not affect an existing pregnancy. My Choice will not protect you from HIV infection (the virus that causes AIDS) and other sexually transmitted diseases (STDs).


When should I use My Choice?

The sooner you take emergency contraception, the better it works. You should use My Choice within 72 hours (3 days) after you have had unprotected sex.


My Choice is a backup or emergency method of birth control you can use when:

  • your regular birth control was used incorrectly or failed
  • you did not use any birth control method

When not to use My Choice.

My Choice should not be used:

  • as a regular birth control method, because it's not as effective as regular birth control.
  • if you are already pregnant, because it will not work.
  • if you are allergic to levonorgestrel or any other ingredients in My Choice.

How does My Choice work?

My Choice is one tablet with levonorgestrel, a hormone that has been used in many birth control pills for several decades. My Choice contains a higher dose of levonorgestrel than birth control pills, but works in a similar way to prevent pregnancy. It works mainly by stopping the release of an egg from the ovary. It is possible that My Choice may also work by preventing fertilization of an egg (the uniting of sperm with the egg) or by preventing attachment (implantation) to the uterus (womb).


How can I get the best results from My Choice?

You have 72 hours (3 days) to try to prevent pregnancy after birth control failure or unprotected sex. The sooner you take My Choice, the better it works.


How effective is My Choice?

If My Choice is taken as directed, it can significantly decrease the chance that you will get pregnant. About 7 out of every 8 women who would have gotten pregnant will not become pregnant.


How will I know My Choice worked?

You will know My Choice has been effective when you get your next period, which should come at the expected time, or within a week of the expected time. If your period is delayed beyond 1 week, it is possible you may be pregnant. You should get a pregnancy test and follow up with your healthcare professional.


Will I experience any side effects?

  • some women may have changes in their period, such as a period that is heavier or lighter or a period that is early or late. If your period is more than a week late, you may be pregnant.
  • if you have severe abdominal pain, you may have an ectopic pregnancy, and should get immediate medical attention.
  • when used as directed, My Choice is safe and effective. Side effects may include changes in your period, nausea, lower stomach (abdominal) pain, tiredness, headache, dizziness, and breast tenderness.
  • if you vomit within 2 hours of taking the medication, call a healthcare professional to find out if you should repeat the dose.

What if I still have questions about My Choice?

If you have questions or need more information, call our toll-free number, 1-800-818-4555.


Other Information

Keep out of reach of children:

In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.


Do not use if the blister seal is opened.

Store at room temperature 20° to 25°C (68° to 77°F).


Active ingredient: levonorgestrel 1.5 mg

Inactive ingredients: colloidal silicon dioxide, hypromellose, magnesium stearate, talc, corn starch, lactose monohydrate


If you are sexually active, you should see a healthcare provider for routine checkups. Your healthcare provider will talk to you about and, if necessary, test you for sexually transmitted diseases, teach you about effective methods of routine birth control, and answer any other questions you may have.


Manufactured by:

Sun Pharmaceutical Ind. Ltd.

Halol-Baroda Highway,

Halol-389 350, Gujarat, India.


Distributed by:
Ohm Laboratories Inc.
New Brunswick, NJ 08901


ISS.03/2017

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PDPPDP

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68071-4247-12024-06-06C16284748780-1ba0f9c33-43b9-a910-e053-dadaa90a0b85My Choice™
68071-4247-12023-01-30C16284748780-1ba0f9c33-43b9-a910-e053-dadaa90a0b85My Choice™
68071-4247-12021-02-16C16284748780-1ba0f9c33-43b9-a910-e053-dadaa90a0b85My Choice™
68071-4247-12021-01-29C16284748780-1ba0f9c33-43b9-a910-e053-dadaa90a0b85My Choice™

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62756-720-60EA - Each62756-720e007cd1b-a844-44b7-bbbc-1595f74adfdf12018-02-20

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68071-424768071-4247-1
62756-720

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A202635-001OPCICON ONE-STEPLEVONORGESTREL1.5MGTABLET / ORAL2014-09-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-1184e616aacf4f…
2026-08-18 06:07:402026-07A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-1174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-1187673890dc5c…
2021-03-12 10:30 UTC2021-03A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-115aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-118869cabd3fbd…
2020-11-12 02:37 UTC2020-11A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11c0c555d07b60…
2019-12-14 00:12 UTC2019-12A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-113f01610625f2…
2019-09-15 20:21 UTC2019-09A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11b00525d2431f…
2019-07-19 19:46 UTC2019-07A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-111c564ffb4f44…
2023-12-20 04:57 UTC2023-12A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-113f0d92c62455…
2023-05-13 08:27 UTC2023-05A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11053a50430f4f…
2023-01-26 05:58 UTC2023-01A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A202635-001OPCICON ONE-STEP1.5MGTABLET / ORAL2014-09-11f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1a3bd4bf-d4b0-126f-e063-6294a90a1be6637737b7-e932-7536-e053-2991aa0af6ec2024-06-06WarningsExact identifier
spl set id: 637737b7-e932-7536-e053-2991aa0af6ec
My Choice TMLEVONORGESTRELSUN PHARMACEUTICAL INDUSTRIES, INC.66753300-fb61-4f09-af74-ee498b0bd5952022-04-21WarningsExact identifier
ndc (product): 62756-720

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.